283 related articles for article (PubMed ID: 27588396)
1. Metastatic lymph node ratio can further stratify risk for mortality in medullary thyroid cancer patients: A population-based analysis.
Qu N; Shi RL; Lu ZW; Liao T; Wen D; Sun GH; Li DS; Ji QH
Oncotarget; 2016 Oct; 7(40):65937-65945. PubMed ID: 27588396
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma.
Leggett MD; Chen SL; Schneider PD; Martinez SR
Ann Surg Oncol; 2008 Sep; 15(9):2493-9. PubMed ID: 18594930
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of lymph node yield and lymph node ratio in well-differentiated thyroid carcinoma.
Beal SH; Chen SL; Schneider PD; Martinez SR
Am Surg; 2010 Jan; 76(1):28-32. PubMed ID: 20135936
[TBL] [Abstract][Full Text] [Related]
4. Survival implications of cervical lymphadenectomy in patients with medullary thyroid cancer.
Kandil E; Gilson MM; Alabbas HH; Tufaro AP; Dackiw A; Tufano RP
Ann Surg Oncol; 2011 Apr; 18(4):1028-34. PubMed ID: 21046269
[TBL] [Abstract][Full Text] [Related]
5. Influence of lymph node metastases on survival in pediatric medullary thyroid cancer.
Raval MV; Sturgeon C; Bentrem DJ; Elaraj DM; Stewart AK; Winchester DJ; Ko CY; Reynolds M
J Pediatr Surg; 2010 Oct; 45(10):1947-54. PubMed ID: 20920711
[TBL] [Abstract][Full Text] [Related]
6. The effect of extent of surgery and number of lymph node metastases on overall survival in patients with medullary thyroid cancer.
Esfandiari NH; Hughes DT; Yin H; Banerjee M; Haymart MR
J Clin Endocrinol Metab; 2014 Feb; 99(2):448-54. PubMed ID: 24276457
[TBL] [Abstract][Full Text] [Related]
7. Exceptionality of Distant Metastasis in Node-Negative Hereditary and Sporadic Medullary Thyroid Cancer: Lessons Learned.
Machens A; Lorenz K; Weber F; Dralle H
J Clin Endocrinol Metab; 2021 Jul; 106(8):e2968-e2979. PubMed ID: 33788951
[TBL] [Abstract][Full Text] [Related]
8. Factors Affecting Central Node Metastasis and Metastatic Lymph Node Ratio in Papillary Thyroid Cancer.
Seok J; Ryu CH; Park SY; Lee CY; Lee YK; Hwangbo Y; Lee EK; Lee YJ; Kim TS; Kim SK; Jung YS; Ryu J
Otolaryngol Head Neck Surg; 2021 Oct; 165(4):519-527. PubMed ID: 33560176
[TBL] [Abstract][Full Text] [Related]
9. Significance of examined lymph nodes number and metastatic lymph nodes ratio in overall survival and adjuvant treatment decision in resected laryngeal carcinoma.
Zhu X; Zhao M; Zhou L; Zhang M; Cao P; Tao L
Cancer Med; 2020 May; 9(9):3006-3014. PubMed ID: 32112627
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance and optimal cutoff of age in medullary thyroid cancer.
Qu N; Shi RL; Luo TX; Wang YL; Li DS; Wang Y; Huang CP; Ji QH
Oncotarget; 2016 Mar; 7(13):15937-47. PubMed ID: 26910117
[TBL] [Abstract][Full Text] [Related]
11. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
Scollo C; Baudin E; Travagli JP; Caillou B; Bellon N; Leboulleux S; Schlumberger M
J Clin Endocrinol Metab; 2003 May; 88(5):2070-5. PubMed ID: 12727956
[TBL] [Abstract][Full Text] [Related]
12. Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study.
Madbouly KM; Abbas KS; Hussein AM
Am J Surg; 2014 Jun; 207(6):824-31. PubMed ID: 24112666
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of lymph node ratio in stage IIIC epithelial ovarian cancer with node-positive in a SEER population-based study.
Zhou J; He ZY; Li FY; Sun JY; Lin HX; Wu SG; Chen QH
Oncotarget; 2016 Feb; 7(7):7952-9. PubMed ID: 26788911
[TBL] [Abstract][Full Text] [Related]
14. The Positive Lymph Node Number and Postoperative N-Staging Used to Estimate Survival in Patients with Differentiated Thyroid Cancer: Results from the Surveillance, Epidemiology, and End Results Dataset (1988-2008).
Wei WJ; Lu ZW; Wen D; Liao T; Li DS; Wang Y; Zhu YX; Wang ZY; Wu Y; Wang YL; Ji QH
World J Surg; 2018 Jun; 42(6):1762-1771. PubMed ID: 29185020
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of lymph node yield and lymph node ratio in papillary thyroid carcinoma.
Vas Nunes JH; Clark JR; Gao K; Chua E; Campbell P; Niles N; Gargya A; Elliott MS
Thyroid; 2013 Jul; 23(7):811-6. PubMed ID: 23373961
[TBL] [Abstract][Full Text] [Related]
16. Survival in patients with medullary thyroid cancer after less than the recommended initial operation.
Randle RW; Bates MF; Schneider DF; Sippel RS; Pitt SC
J Surg Oncol; 2018 May; 117(6):1211-1216. PubMed ID: 29266278
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of preoperative 18F-FDG PET/CT in papillary thyroid cancer patients with a high metastatic lymph node ratio: a multicenter retrospective cohort study.
Kwon SY; Choi EK; Kong EJ; Chong A; Ha JM; Chun KA; Cho IH; Bom HS; Min JJ; Kim J; Song HC; O JH; Kim SH
Nucl Med Commun; 2017 May; 38(5):402-406. PubMed ID: 28306621
[TBL] [Abstract][Full Text] [Related]
18. The number and ratio of positive lymph nodes are independent prognostic factors for patients with major salivary gland cancer: Results from the surveillance, epidemiology, and End Results dataset.
Qian K; Sun W; Guo K; Zheng X; Sun T; Chen L; Xiang J; Li D; Wu Y; Ji Q; Wang Z
Eur J Surg Oncol; 2019 Jun; 45(6):1025-1032. PubMed ID: 30472214
[TBL] [Abstract][Full Text] [Related]
19. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.
Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH
Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905
[TBL] [Abstract][Full Text] [Related]
20. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
